Elevated levels of circulating IgG1 and IgG3 class-switched anti-HSP90 autoantibodies have been consistently identified in individuals in the latent or pre-clinical stages of T1D, suggesting HSP90 as a potential biomarker for early detection of T1D (23). This evidence concerns the gene IGHG3 and type 1 diabetes mellitus.